Abstract
This thesis shed light on the complex and heterogeneous nature of (long) COVID. It contributed to the characterization of both acute COVID-19 and long COVID patients and the identification of individuals at risk of developing chronic lung damage. It covered research ranging from pharmacokinetic and pharmacodynamic studies on the
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 28 Feb 2025 |
| Print ISBNs | 9789465104539 |
| Publication status | Published - 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Towards precision medicine for (long) COVID: Perspectives on pharmacotherapy and molecular mechanisms'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver